110341 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Gammaretrovirus, e.g. murine leukeamia virus; Use of virus, viral particle or viral elements as a vector Special targeting system for viral vectors
Retroviral and Lentiviral Vectors
#2COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#3COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#4COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#5COMPOSITIONS AND METHODS FOR EFFICIENT IN VIVO DELIVERY
#6EX VIVO ANTIBODY PRODUCTION
#7Retroviral And Lentiviral Vectors
#8Retroviral and lentiviral vectors
#9Ex vivo antibody production
#10Packaging cell for making a pseudotyped lentivirus
#11Retroviral and lentiviral vectors
#12Methods of delivering a pseudotyped lentivirus
#13Retroviral and lentiviral vectors
#14EX VIVO ANTIBODY PRODUCTION
#15Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#16Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same
#17Replication competent pseudo-type retrovirus vector system
#18Method of stimulating an immune response using a pseudotyped lentivirus
#19Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#20Therapeutic Use of Growth Factor, and Delivery Device, Especially for the Treatment of Intimal Hyperplasia
#21Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#22Retroviral vector particles and methods for their generation and use
#23Method for the production of antibodies that bind to multiple membrane spanning proteins
#24Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same
#25Targeted gene delivery to dendritic cells
#26Gene delivery system and method of use
#27Method of transducing non-dividing myeloid cells utilizing chimeric murine leukemia viruses containing Vpx
#28ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION
#29Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#30Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof
#31Compositions and methods for monosynaptic transport
#32Method for the preparation of virus-like particles (VLPS) comprising heterologous multiple membrane spanning proteins
#33Targeted vectors for cancer immunotherapy
#34Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#35Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#36Pathotropic targeted gene delivery system for cancer and other disorders
#37Foamy viral envelope genes
#38Chimeric viral envelopes
#39Pseudotyped retroviral vectors and methods of use thereof
#40Enhancement of retroviral gene transduction employing polypeptides comprising the fibronectin heparin II binding domain
#41Method for transfer of gene into fat cell or progenitor fat cell
#42MOMLV-BASED PSEUDOVIRION PACKAGING CELL LINE
#43PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#44Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains
#45Novel sequences encoding hepatitis C virus glycoproteins
#46Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
#47Methods for transfecting natural killer cells
#48Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
#49Compositions and Methods for Elimination of Unwanted Cells
#50Compositions and Methods for Elimination of Unwanted Cells
#51T Cell Line-Based Packaging Cell Line for the Production of Retroviruses by Enriching of Cd3 Expressing Cells
#52Compositions and methods for monosynaptic transport
#53Methods and compositions for modulating apoptotic pathways
#54Compositions and Methods for Elimination of Unwanted Cells
#55Compositions and methods for elimination of unwanted cells
#56Targeted artificial gene delivery
#57Lentivirus vectors for gene transfer to alveolar epithelial cells
#58GENE TRANSFER METHODS
#59Targeted gene delivery for dendritic cell vaccination
#60Process for the removal of selectable marker gene sequences
#61Cancer cell targeting gene delivery method
#62PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#63Infectious pestivirus pseudo-particles containing functional Erns, E1, E2 envelope proteins
#64Retroviral vectors including modified envelope escort protein
#65Targeted vectors for cancer immunotherapy
#66Endothelial cell specifically binding peptides
#67Viral vectors with surface or envelope components
#68Process for preparing retrovirus vector for gene therapy
#69Methods and means for targeted gene delivery
#70Method for mitochondrial targeting of p53
#71Methods of making viral particles having a modified cell binding activity and uses thereof
#72Retroviral delivery system
#73Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#74Purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
#75Compositions and methods for elimination of unwanted cells
#76Method for gene transfer into target cells with retrovirus
#77Sequences encoding hepatitis C virus glycoproteins
#78Method of delivering therapeutic agents to site of tissue injury
#79Altering viral tropism
#80Lentiviral vectors derived from SIVsmm/PBj14, method for their production and uses thereof
#81Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer
#82Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
#83Pseudotyped viruses and methods for their use
#84Gene delivery system and methods of use